Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 56

1.

Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C Coinfected Persons.

Chew KW, Bhattacharya D, McGinnis K, Horwich TB, Tseng CH, Currier J, Butt AA.

AIDS Res Hum Retroviruses. 2015 Apr 9. [Epub ahead of print]

PMID:
25858663
2.

Obesity and the obesity paradox in heart failure.

Gupta PP, Fonarow GC, Horwich TB.

Can J Cardiol. 2015 Feb;31(2):195-202. doi: 10.1016/j.cjca.2014.08.004. Epub 2014 Aug 15. Review.

PMID:
25661554
3.

Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure.

Clark AL, Fonarow GC, Horwich TB.

Am J Cardiol. 2015 Jan 15;115(2):209-13. doi: 10.1016/j.amjcard.2014.10.023. Epub 2014 Oct 30.

PMID:
25465933
4.

Response to letter regarding article, "Four-variable risk model in men and women with heart failure".

Horwich TB, Tseng CH, Fonarow GC, Chyu J.

Circ Heart Fail. 2014 Mar 1;7(2):381. No abstract available.

5.

Obesity and the obesity paradox in heart failure.

Clark AL, Fonarow GC, Horwich TB.

Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):409-14. doi: 10.1016/j.pcad.2013.10.004. Epub 2013 Oct 5. Review.

PMID:
24438732
6.

Four-variable risk model in men and women with heart failure.

Chyu J, Fonarow GC, Tseng CH, Horwich TB.

Circ Heart Fail. 2014 Jan;7(1):88-95. doi: 10.1161/CIRCHEARTFAILURE.113.000404. Epub 2013 Nov 26.

7.

Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins.

Kim JB, Hama S, Hough G, Navab M, Fogelman AM, Maclellan WR, Horwich TB, Fonarow GC.

Am J Cardiol. 2013 Dec 1;112(11):1770-7. doi: 10.1016/j.amjcard.2013.07.045. Epub 2013 Sep 16.

PMID:
24050409
8.

Obesity in heart failure: impact on survival and treatment modalities.

Cheng RK, DePasquale EC, Deng MC, Nsair A, Horwich TB.

Expert Rev Cardiovasc Ther. 2013 Sep;11(9):1141-53. doi: 10.1586/14779072.2013.824691. Epub 2013 Aug 14. Review.

PMID:
23944985
9.

Intact skeletal muscle mitochondrial enzyme activity but diminished exercise capacity in advanced heart failure patients on optimal medical and device therapy.

Middlekauff HR, Verity MA, Horwich TB, Fonarow GC, Hamilton MA, Shieh P.

Clin Res Cardiol. 2013 Aug;102(8):547-54. doi: 10.1007/s00392-013-0564-3. Epub 2013 Apr 11.

10.

Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center.

Loh JC, Creaser J, Rourke DA, Livingston N, Harrison TK, Vandenbogaart E, Moriguchi J, Hamilton MA, Tseng CH, Fonarow GC, Horwich TB.

Circ Heart Fail. 2013 May;6(3):411-9. doi: 10.1161/CIRCHEARTFAILURE.112.000178. Epub 2013 Mar 11.

11.

Abnormalities of calcium handling proteins in skeletal muscle mirror those of the heart in humans with heart failure: a shared mechanism?

Middlekauff HR, Vigna C, Verity MA, Fonarow GC, Horwich TB, Hamilton MA, Shieh P, Tupling AR.

J Card Fail. 2012 Sep;18(9):724-33. doi: 10.1016/j.cardfail.2012.07.005.

12.

The obesity paradox in men versus women with systolic heart failure.

Clark AL, Chyu J, Horwich TB.

Am J Cardiol. 2012 Jul 1;110(1):77-82. doi: 10.1016/j.amjcard.2012.02.050. Epub 2012 Apr 10.

13.

Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.

Tomova GS, Nimbal V, Horwich TB.

Am J Cardiol. 2012 Jun 15;109(12):1767-73. doi: 10.1016/j.amjcard.2012.02.022. Epub 2012 Mar 27.

14.

The obesity paradox: time for a new look at an old paradigm.

Srikanthan P, Horwich TB.

Rev Esp Cardiol (Engl Ed). 2012 May;65(5):403-4. doi: 10.1016/j.recesp.2011.12.011. Epub 2012 Mar 10. English, Spanish. No abstract available.

PMID:
22406399
15.

Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.

Horwich TB, Middlekauff HR, Maclellan WR, Fonarow GC.

J Card Fail. 2011 Nov;17(11):879-86. doi: 10.1016/j.cardfail.2011.07.008. Epub 2011 Sep 3.

16.

Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure.

Horwich TB, Broderick S, Chen L, McCullough PA, Strzelczyk T, Kitzman DW, Fletcher G, Safford RE, Ewald G, Fine LJ, Ellis SJ, Fonarow GC.

Am J Cardiol. 2011 Dec 15;108(12):1754-9. doi: 10.1016/j.amjcard.2011.07.051. Epub 2011 Sep 9.

17.

Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited.

Clark AL, Fonarow GC, Horwich TB.

J Card Fail. 2011 May;17(5):374-80. doi: 10.1016/j.cardfail.2011.01.009. Epub 2011 Mar 25.

PMID:
21549293
18.

Epidemiology and risk profile of heart failure.

Bui AL, Horwich TB, Fonarow GC.

Nat Rev Cardiol. 2011 Jan;8(1):30-41. doi: 10.1038/nrcardio.2010.165. Epub 2010 Nov 9. Review.

19.

Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.

Sachdeva A, Horwich TB, Fonarow GC.

Am J Cardiol. 2010 Sep 15;106(6):830-5. doi: 10.1016/j.amjcard.2010.04.045. Epub 2010 Aug 1.

PMID:
20816124
20.

Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.

Shah DD, Fonarow GC, Horwich TB.

J Card Fail. 2010 Mar;16(3):200-6. doi: 10.1016/j.cardfail.2009.10.022. Epub 2009 Nov 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk